The Study On The Validity And Optimization Of Guangxi’s Biological Medicine Industry Fiscal Policy

High and new technology industries,such as the biological medicine industry,is the pillar industry in the era of knowledge economy,and it is also the most promising sunrise industry at present.Vigorously developing the biological medicine industry plays an important role:in the adjustment of China’s economic structure,the change in economic growth mode,and the sustainable development of the economy.Due to the high input and high risk characteristics of the biological medicine industry,its development cannot be separated from the strong support of the government,especially the support of fiscal policy.The direct input of government financial funds,financial subsidies,government procurement and tax incentives have been playing an irreplaceable role in the development of the biological medicine industry.In this paper,takes the Guangxi Zhuang Autonomous Region as an example,based on the market failure theory and the industrial life cycle theory,this paper uses the literature research method、the combination of qualitative and quantitative methods、the comparative analysis method to study the fiscal policy of Guangxi biological medicine industry.Through research,we found that the biological medicine industry in Guangxi has made great progress in recent years under the support of the government,,but there is still a big gap compared with the developed regions.This paper evaluates the overall performance of the fiscal policy of Guangxi biological medicine industry,and uses spss software to measure and analyze the effectiveness of the fiscal policy.It is found that there are still some problems in the fiscal policy implemented by Guangxi to promote the development of biomedical industry.For example,the total amount of financial investment is insufficient and the structure is irrational、the use rate of financial input funds is low、the tax preferential policies are not perfect,and the system is not systematic、the support of small and medium-sized enterprises is not enough,and the existing fiscal policy has no significant effect on the incentive effect of R&D personnel.In view of the above problems,based on the relevant experience of the financial policies implemented by the developed countries such as New York,London,and Tokyo,from the perspective of the industrial life cycle,according to the different stages of development of the Guangxi biological medicine industry,this paper puts forward relevant suggestions,and try to provide a reference for the study of relevant policies in other provinces and cities.